To amend title XVIII of the Social Security Act to exempt certain drugs from the part D manufacturer discount program under the Medicare program.

Cost and committee reports

Official records Congress.gov attaches to H.R. 10305.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. GARBARINO, as printed in the Congressional Record (Vol. 170, No. 180, December 5, 2024, Page H6414):
  Art. 1, Sec. 8. The single subject of this legislation is: The bill would exempt certain drugs from the part D manufacturer discount program under the Medicare program.
  Source: Congress.gov, Congressional Record December 5, 2024 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  168 characters

  Congress.gov bill record

  H.R. 10305, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/10305

  Record last updated by Congress.gov

  August 18, 2025

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  55fa34111cce03b7449c4e7d1572b2bbdde9ca463b9506bce5f27fd3434aab0c

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of August 18, 2025). Not every bill gets one.

From the Congress.gov bill record for H.R. 10305, last updated August 18, 2025. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.